These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35135394)

  • 1. Effect of hidradenitis suppurativa on obstetric and neonatal outcomes.
    Althagafi H; Spence AR; Czuzoj-Shulman N; Abenhaim HA
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8388-8393. PubMed ID: 35135394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of pregnancy and childbirth in women with hidradenitis suppurativa.
    Sakya SM; Hallan DR; Maczuga SA; Kirby JS
    J Am Acad Dermatol; 2022 Jan; 86(1):61-67. PubMed ID: 34153386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa.
    Fitzpatrick L; Hsiao J; Tannenbaum R; Strunk A; Garg A
    J Am Acad Dermatol; 2022 Jan; 86(1):46-54. PubMed ID: 34126093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
    Kirby JS; Miller JJ; Adams DR; Leslie D
    JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
    Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
    Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy, delivery, and neonatal outcomes among women with irritable bowel syndrome (IBS) an evaluation of over 9 million deliveries.
    Alnoman A; Badeghiesh AM; Baghlaf HA; Dahan MH
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5935-5942. PubMed ID: 33823718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis Suppurativa in Sweden: A Registry-Based Cross-Sectional Study of 13,538 Patients.
    Killasli H; Sartorius K; Emtestam L; Svensson Å
    Dermatology; 2020; 236(4):281-288. PubMed ID: 32015234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetrical and neonatal outcomes among pregnancies complicated by hyperparathyroidism.
    Trahan MJ; Antinora C; Czuzoj-Shulman N; Benjamin A; Abenhaim HA
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2170748. PubMed ID: 36775282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
    Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
    JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy, delivery and neonatal outcomes among women with diabetic retinopathy.
    Alnoman A; Peeva M; Badeghiesh AM; Baghlaf HA; Dahan MH
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10621-10628. PubMed ID: 36404423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States.
    Garg A; Kirby JS; Lavian J; Lin G; Strunk A
    JAMA Dermatol; 2017 Aug; 153(8):760-764. PubMed ID: 28492923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa.
    Khalsa A; Liu G; Kirby JS
    J Am Acad Dermatol; 2015 Oct; 73(4):609-14. PubMed ID: 26190241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early preterm preeclampsia outcomes by intended mode of delivery.
    Coviello EM; Iqbal SN; Grantz KL; Huang CC; Landy HJ; Reddy UM
    Am J Obstet Gynecol; 2019 Jan; 220(1):100.e1-100.e9. PubMed ID: 30273585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-eclampsia: incidence, determinants, and pregnancy outcomes from maternity hospitals in Qatar: a population-based case-control study.
    Maducolil MK; Al-Obaidly S; Olukade T; Salama H; AlQubaisi M; Al Rifai H
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7831-7839. PubMed ID: 34112060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial Cystitis/Bladder Pain Syndrome's Correlations with Pregnancy and Neonatal Outcomes: A Study of a Population Database.
    Khojah MI; Badeghiesh AM; Ismail S; Baghlaf HA; Almamlouk N; Dahan MH
    J Urol; 2021 Oct; 206(4):978-985. PubMed ID: 34032499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcomes after thyroid cancer.
    Spiegel E; Spence AR; Czuzoj-Shulman N; Abenhaim HA
    J Perinat Med; 2019 Sep; 47(7):710-716. PubMed ID: 31323010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient ischemic attack and pregnancy, delivery and neonatal outcomes-An evaluation of a population database.
    Amikam U; Badeghiesh A; Baghlaf H; Brown R; Dahan MH
    Int J Gynaecol Obstet; 2024 Jul; 166(1):412-418. PubMed ID: 38311958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Aug; 35(8):1914-1921. PubMed ID: 32644124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study.
    Tzur Bitan D; Berzin D; Cohen AD
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):574-579. PubMed ID: 31587377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.